How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Hoffmann-La Roche, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
49 clearance records and 0 recall records in the covered releases, across 1 source company names and 30 product codes. Dated history runs from Jul 20, 1976 to Jun 25, 1985.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| BHCG-ROCHE EIAK850727 · JHI | Hoffmann-La Roche, Inc. | 510(k) | Jun 25, 1985FDA decision date |
| RENAKK831694 · CIB | Hoffmann-La Roche, Inc. | 510(k) | Jul 19, 1983FDA decision date |
| ABUSCREEN RADIOIMMUNOASSAY FOR MORPHINEK830460 · DOE | Hoffmann-La Roche, Inc. | 510(k) | Mar 24, 1983FDA decision date |
| ABUSCREEN RADIOUMMUNOASSAY-METHAQUALONEK830461 · KXS | Hoffmann-La Roche, Inc. | 510(k) | Mar 24, 1983FDA decision date |
| ABUSCREEN RADIOUMMUNOASSAY--URINEK830462 · DOE | Hoffmann-La Roche, Inc. | 510(k) | Mar 24, 1983FDA decision date |
| ABUSCREEN RADIOIMMUNOASSAY-COCAINE METAK830480 · KLN | Hoffmann-La Roche, Inc. | 510(k) | Mar 24, 1983FDA decision date |
| ABUSCREEN RADIOIMMUNOASSAY-PHENCYCLIDINEK830481 · LCL | Hoffmann-La Roche, Inc. | 510(k) | Mar 24, 1983FDA decision date |
| ABUSCREEN RADIOIMMUNOASSAY-AMPHETAMINEK830482 · DJP | Hoffmann-La Roche, Inc. | 510(k) | Mar 24, 1983FDA decision date |
| ABUSCREEN RADIOIMMUNOASSAY-BARBITURATEK830479 · DKN | Hoffmann-La Roche, Inc. | 510(k) | Mar 10, 1983FDA decision date |
| COBAS STANDARDS FOR CREATININEK823572 · CGX | Hoffmann-La Roche, Inc. | 510(k) | Jan 7, 1983FDA decision date |
| COBAS REAGENT FOR CREATININEK823573 · CGX | Hoffmann-La Roche, Inc. | 510(k) | Jan 7, 1983FDA decision date |
| COBAS REAGENT FOR ALBUMINK823574 · CIX | Hoffmann-La Roche, Inc. | 510(k) | Jan 7, 1983FDA decision date |
| COBAS STANDARDS FOR ALBUMINK823575 · CIX | Hoffmann-La Roche, Inc. | 510(k) | Jan 7, 1983FDA decision date |
| COBAS STANDARD FOR TOTAL PROTEINK823576 · LER | Hoffmann-La Roche, Inc. | 510(k) | Jan 7, 1983FDA decision date |
| COBAS REAGENT FOR CALCIUMK823577 · CIC | Hoffmann-La Roche, Inc. | 510(k) | Jan 7, 1983FDA decision date |
| COBAS STANDARDS FOR CALCIUM-IN-ORGANICK823578 · CIO | Hoffmann-La Roche, Inc. | 510(k) | Jan 7, 1983FDA decision date |
| COBAS REAGENT FOR TOTAL PROTEINK823579 · CEK | Hoffmann-La Roche, Inc. | 510(k) | Jan 7, 1983FDA decision date |
| COBAS REAGENT FOR INORGANIC PHOSPHORUSK823580 · CEO | Hoffmann-La Roche, Inc. | 510(k) | Jan 7, 1983FDA decision date |
| HUMAN PLASMA CONTROL FOR CEA-ROCHEK822219 · JJX | Hoffmann-La Roche, Inc. | 510(k) | Dec 28, 1982FDA decision date |
| ABUSCREEN RADIOIMMUNOASSAY - AMPHETAMINEK823212 · DJP | Hoffmann-La Roche, Inc. | 510(k) | Nov 29, 1982FDA decision date |
| ROCHE(R) B-HCG RIA URINE STANDARDK820942 · JHI | Hoffmann-La Roche, Inc. | 510(k) | May 3, 1982FDA decision date |
| ROCHE B-HCG RIAK820613 · JHI | Hoffmann-La Roche, Inc. | 510(k) | Apr 1, 1982FDA decision date |
| ROCHE B-HCG STANDARDSK820614 · JHI | Hoffmann-La Roche, Inc. | 510(k) | Apr 1, 1982FDA decision date |
| ABUSCREEN RADIOIMMUNOASSAY FOR CANNABIK820391 · LAT | Hoffmann-La Roche, Inc. | 510(k) | Mar 8, 1982FDA decision date |
| AGGLUTEX AMPHETAMINE TEST KITK812986 · DJP | Hoffmann-La Roche, Inc. | 510(k) | Jan 22, 1982FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.